New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 3, 2014
08:17 EDTCPIXCumberland acquires Vaprisol from Astellas Pharma US
Cumberland Pharmaceuticals announced the acquisition of Vaprisol from Astellas Pharma US. Vaprisol is a patented, prescription brand indicated to raise serum sodium levels in hospitalized patients with hyponatremia. Under the terms of the agreement, Cumberland will assume full responsibility for the product including its marketing, distribution and manufacture.
News For CPIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 23, 2015
16:08 EDTCPIXCumberland launches Caldolor in Australia
Subscribe for More Information
09:22 EDTCPIXCumberland announces approval of Caldolor injection
Cumberland announced the approval of Caldolor Injection for pediatric patients six months of age and older. The approval was based on data submitted to the U.S. Food and Drug Administration (FDA) as part of a post-marketing commitment following approval of Caldolor in adults in 2009. Caldolor is the first and only injectable non-steroidal anti-inflammatory drug approved for use in pediatric patients.
November 20, 2015
09:21 EDTCPIXCumberland announces favorable Acetadote patent ruling
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use